MATTHEW HISLOP: Open Payments
NPI 1174062491 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,054 in 186 payments from 23 companies in 2025. Trend: 2023 $1,111 · 2024 $1,805 · 2025 $3,054
Food & beverage: $2,887Education: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $454 |
| PFIZER INC. | 30 | $373 |
| UCB, Inc. | 17 | $339 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 21 | $300 |
| Janssen Biotech, Inc. | 19 | $274 |
| Amgen Inc. | 11 | $195 |
| Regeneron Healthcare Solutions, Inc. | 12 | $178 |
| Lilly USA, LLC | 9 | $170 |
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| Galderma Laboratories, L.P. | 6 | $103 |
Products named: Bimzelx, SKYRIZI, TREMFYA, CIBINQO, DUPIXENT, OTEZLA, RINVOQ, COSENTYX.
Industry payments across NY — which companies pay providers there.
